How does the FDA Modernisation Act 2.0 impact seizure liability testing in drug discovery?

<p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">The latest sponsored DDW Sitting Down With podcast features Ruth Roberts and Michael Morton,</span> <span lang="EN-US" xml:lang= "EN-US">co-founders of ApconiX,</span> <span lang="EN-US" xml:lang= "EN-US">and Dr Kimberly Rockley</span><span lang="EN-US" xml:lang= "EN-US">,</span> <span lang="EN-US" xml:lang="EN-US">ApconiX, who discuss novel alternative methods and the impact of the FDA Modernisation Act 2.0 in relation to seizure liability as well as talking about the importance of evaluating seizure liability<span class="msoIns"><ins cite="mailto:Cynara%20Livera" datetime="2023-08-31T15:07">.</ins></span></span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">The speakers outline how new research supports the refinement and replacement of the use of animals in safety testing, and how new assays could save time and money in drug discovery.</span></p> <p class="MsoNormal"><span lang="EN-US" xml:lang="EN-US">Listen now.</span></p>